Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.62 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | LDHA | P00338 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3125590 | 0.91 | DRD2 (0.64) | DRD2MTNR1AMTNR1BTRPV1CA12 | |
| SCHEMBL3119217 | 0.89 | DRD2 (0.62) | DRD2TRPV1CA12CA1CA2 | |
| SCHEMBL3111579 | 0.88 | DRD2 (0.61) | DRD2TRPV1EPHX2 | |
| SCHEMBL3123728 | 0.87 | DRD2 (0.60) | DRD2TRPV1EPHX2 | |
| SCHEMBL3123865 | 0.87 | DRD2 (0.60) | DRD2TRPV1EPHX2 | |
| SCHEMBL3126040 | 0.87 | DRD2 (0.60) | DRD2TRPV1EPHX2 | |
| SCHEMBL3125007 | 0.87 | DRD2 (0.60) | DRD2TRPV1EPHX2 | |
| SCHEMBL3125726 | 0.87 | DRD2 (0.60) | DRD2TRPV1EPHX2 | |
| SCHEMBL3123972 | 0.87 | DRD2 (0.60) | DRD2TRPV1EPHX2 | |
| SCHEMBL3121314 | 0.87 | DRD2 (0.60) | DRD2TRPV1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100256413-A1 | METHOD FOR THE CHEMICAL SYNTHESIS OF CAPSINOIDS | UNIVERSIDAD DE CÁDIZ (ES) | 2010-10-07 | — | — | US | disclosed |
| EP-2149548-A1 | METHOD FOR THE CHEMICAL SYNTHESIS OF CAPSINOIDS | Universidad De Cádiz (ES) | 2010-02-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256413-A1 | METHOD FOR THE CHEMICAL SYNTHESIS OF CAPSINOIDS | CES2, ACACB, TES | DRD2 908/4885MTNR1A 4569/4885MTNR1B 4582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.